Events and Webinars
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
Pooja Joshi, MD
Medical Science Liaison, Vaccines
Dr. Pooja Joshi has been representing GSK since 2017. She earned her MD in Pharmacology & Therapeutics from MUHS, India. During her residency, she trained in pre-clinical and clinical research studies, was a coordinator for the Phase 3 & 4 clinical trials. She was also lecturer for students of medicine and nursing. Prior to joining GSK, Pooja supported therapeutic area of diabetes in the pharmaceutical industry. Before beginning her industry career, she was an assistant medical officer at King Edward Memorial Hospital, India.
- 1h 30m
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.Related Events and Webinars
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
IMPORTANT SAFETY INFORMATION
- SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine or after a previous dose of SHINGRIX
- Review immunization history for possible vaccine sensitivity and previous vaccination-related adverse reactions. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of SHINGRIX
- Solicited local adverse reactions in subjects aged 50 years and older were pain (78.0%), redness (38.1%), and swelling (25.9%)
- Solicited general adverse reactions in subjects aged 50 years and older were myalgia (44.7%), fatigue (44.5%), headache (37.7%), shivering (26.8%), fever (20.5%), and gastrointestinal symptoms (17.3%)
- SHINGRIX was not studied in pregnant or lactating women, and it is unknown if it is excreted in human milk. Therefore, it cannot be established whether there is vaccine-associated risk with SHINGRIX in pregnant women or if there are effects on breastfed infants or milk production/excretion
- Vaccination with SHINGRIX may not result in protection of all vaccine recipients
Trademarks are property of their respective owners.
1009353R0 September 2018
INDICATION
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).